Manoranjan Kumar
About Manoranjan Kumar
Data last updated:
Manoranjan Kumar is a Director at Curonest Pharmaceuticals Private Limited (since 2020) and Director at Curonest Lifestyle Private Limited (since 2020). The companies operate in Trading and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹38.6 Lakh; the largest is Curonest Pharmaceuticals Private Limited at ₹38.1 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Curonest Pharmaceuticals Private Limited U51909KA2020PTC133817 | Director | 18 Apr 2020 | 2020 | ₹38.1 Lakh (FY 2024) | Active |
| Curonest Lifestyle Private Limited U67100JH2020PTC015455 | Director | 02 Nov 2020 | 2020 | ₹52,144 (FY 2022) | Active |
Board colleagues of Manoranjan Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rishi Ranjan | 02693425 | Curonest Pharmaceuticals Private Limited , Curonest Lifestyle Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manoranjan Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manoranjan Kumar
Manoranjan Kumar currently holds 2 directorships: Curonest Pharmaceuticals Private Limited (Director, since 18 Apr 2020, revenue ₹38.1 Lakh (FY 2024)); Curonest Lifestyle Private Limited (Director, since 02 Nov 2020, revenue ₹52,144 (FY 2022)).
Manoranjan Kumar was first appointed on 18 Apr 2020 as Director at Curonest Pharmaceuticals Private Limited.
The 2 current companies of Manoranjan Kumar that report revenue have a combined latest revenue of ₹38.6 Lakh: Curonest Pharmaceuticals Private Limited ₹38.1 Lakh (FY 2024); Curonest Lifestyle Private Limited ₹52,144 (FY 2022).
The current boards of Manoranjan Kumar's companies include Rishi Ranjan (Curonest Pharmaceuticals Private Limited).